骨髓灰质炎 (Myasthenia gravis) 是一个严重的疾病.

Same author

Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes.

Journal of neuroimmunology·2005

Same author

Antibodies associated with paraneoplastic neurological disorders.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2005

Same author

Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis.

Journal of neurology, neurosurgery, and psychiatry·2005

Same author

Sequential antibodies to potassium channels and glutamic acid decarboxylase in neuromyotonia.

Neurology·2005

Same author

FDG-PET and MRI in potassium channel antibody-associated non-paraneoplastic limbic encephalitis: correlation with clinical course and neuropsychology.

Acta neurologica Scandinavica·2005

Same author

Grapefruit juice-nifedipine interaction: possible involvement of several mechanisms.

Journal of clinical pharmacy and therapeutics·2005

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

相关实验视频

骨髓灰质炎 (Myasthenia gravis) 是一个严重的疾病.

相关概念视频

Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes.

Antibodies associated with paraneoplastic neurological disorders.

Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis.

Sequential antibodies to potassium channels and glutamic acid decarboxylase in neuromyotonia.

FDG-PET and MRI in potassium channel antibody-associated non-paraneoplastic limbic encephalitis: correlation with clinical course and neuropsychology.

Grapefruit juice-nifedipine interaction: possible involvement of several mechanisms.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

相关实验视频

骨髓灰质炎 (Myasthenia gravis) 是一个严重的疾病.

相关概念视频

相关文章

Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes.

Antibodies associated with paraneoplastic neurological disorders.

Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis.

Sequential antibodies to potassium channels and glutamic acid decarboxylase in neuromyotonia.

FDG-PET and MRI in potassium channel antibody-associated non-paraneoplastic limbic encephalitis: correlation with clinical course and neuropsychology.

Grapefruit juice-nifedipine interaction: possible involvement of several mechanisms.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.